Chartwell Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,927
Closed -$3.85M 432
2023
Q2
$3.85M Buy
10,927
+1,038
+10% +$350K 0.14% 228
2023
Q1
$3.12M Hold
9,889
0.12% 237
2022
Q4
$2.86M Buy
9,889
+6,399
+183% +$1.95M 0.11% 236
2022
Q3
$1.01M Hold
3,490
0.04% 348
2022
Q2
$983K Sell
3,490
-4,055
-54% -$1.09M 0.04% 358
2022
Q1
$1.97M Buy
7,545
+441
+6% +$105K 0.07% 298
2021
Q4
$1.56M Buy
7,104
+1,703
+32% +$331K 0.05% 342
2021
Q3
$980K Hold
5,401
0.03% 379
2021
Q2
$1.09M Sell
5,401
-10,487
-66% -$2.19M 0.03% 368
2021
Q1
$3.42M Sell
15,888
-1,553
-9% -$341K 0.1% 233
2020
Q4
$4.12M Sell
17,441
-4,531
-21% -$1.04M 0.13% 211
2020
Q3
$5.98M Buy
21,972
+1,667
+8% +$460K 0.22% 162
2020
Q2
$5.89M Buy
20,305
+611
+3% +$166K 0.23% 168
2020
Q1
$4.69M Sell
19,694
-245
-1% -$56.2K 0.22% 164
2019
Q4
$4.37M Sell
19,939
-24
-0.1% -$4.86K 0.14% 200
2019
Q3
$3.38M Sell
19,963
-371
-2% -$65.6K 0.11% 242
2019
Q2
$3.73M Sell
20,334
-2,188
-10% -$383K 0.12% 239
2019
Q1
$4.14M Sell
22,522
-3,769
-14% -$696K 0.13% 229
2018
Q4
$4.36M Buy
26,291
+2,689
+11% +$466K 0.15% 203
2018
Q3
$4.55M Buy
23,602
+3,151
+15% +$561K 0.13% 229
2018
Q2
$3.48M Buy
20,451
+13,765
+206% +$2.13M 0.1% 264
2018
Q1
$1.09M Buy
6,686
+42
+0.6% +$6.86K 0.04% 369
2017
Q4
$996K Sell
6,644
-4,418
-40% -$654K 0.03% 385
2017
Q3
$1.68M Buy
11,062
+7,690
+228% +$1.16M 0.06% 341
2017
Q2
$435K Buy
+3,372
New +$406K 0.02% 399
2017
Q1
Sell
-9,375
Closed -$691K 447
2016
Q4
$691K Sell
9,375
-60,340
-87% -$4.91M 0.02% 387
2016
Q3
$6.08M Buy
+69,715
New +$6.59M 0.11% 227
2013
Q4
Sell
-88,630
Closed -$6.72M 372
2013
Q3
$6.72M Buy
+88,630
New +$7.05M 0.15% 225

Other funds holding VRTX